SMMT — Summit Therapeutics Inc. stock price, charts and financials

QT12Summit Therapeutics Inc.

Summit Therapeutics Inc. (NASDAQ: SMMT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
13.76
+0.71+5.44%
OverviewShort InterestFilings
SMMTQT12Summit Therapeutics Inc.·NASDAQ
13.76+5.44%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 23, 20268-KCurrent report
Jul 23, 20268-KCurrent report
Jul 23, 2026424B5Prospectus
Jul 23, 202610-QQuarterly report
Jul 22, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 11, 20268-KCurrent report
Jun 10, 2026424B5Prospectus
Jun 09, 2026S-3ASRS-3ASR
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 03, 20268-KCurrent report
Jun 01, 20268-KCurrent report
Apr 30, 20268-KCurrent report
Apr 30, 202610-QQuarterly report
Apr 17, 2026DEFA14AAdditional proxy soliciting materials
Apr 17, 2026ARSAnnual report to shareholders
Apr 17, 2026DEF 14ADefinitive proxy statement
Apr 06, 2026PRE 14APreliminary proxy statement
Feb 23, 20268-KCurrent report
Feb 23, 202610-KAnnual report
Feb 23, 2026S-8Registration of employee benefit securities
#1 / 25 of 274
Page
▼
/ 11